Latest filing published 03 Nov 2016 for ImmunoGen, Inc., €4,241.
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
John Lambert: trading record in brief
All filings by John Lambert on record concern ImmunoGen, Inc. We count 109 filings; the first trade dates from 3 March 2006 and the latest from 2 November 2016.
The open-market side counts 1 purchase for €4,241 alongside 66 sales for €3.4M. Taken together, the sales exceed the purchases by €3.4M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 42 option exercises. 2016 to date brings 1 purchase and 2 sales.
The record was last updated on 3 November 2016 with an open-market purchase (€4,241) in ImmunoGen, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to John Lambert
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,775 shares@ US$1.693.3% of flowCommon StockSEC:0001179110-16-031103:0Canonical exit: 31 Jan 2017 (T+90)
- 3,889 shares@ US$3.198.7% of flowCommon StockSEC:0001179110-16-020229:0
- 7,000 shares@ US$5.7728.4% of flowCommon StockSEC:0001179110-16-020229:1
- 3,889 sharesCommon StockSEC:0001179110-16-018159:0
- 3,889 shares@ US$8.220938.4% of flowCommon StockSEC:0001179110-16-018159:1
- 3,889 sharesCommon StockSEC:0001179110-16-016896:0
- 3,889 shares@ US$13.20161.6% of flowCommon StockSEC:0001179110-16-016896:1
- 3,889 shares@ US$3.19Common StockSEC:0001179110-15-015534:0
- 3,889 shares@ US$13.11Common StockSEC:0001179110-15-015534:1
- 3,889 shares@ US$3.19Common StockSEC:0001179110-15-014353:0
- 3,889 shares@ US$11.73Common StockSEC:0001179110-15-014353:1
- 3,889 shares@ US$3.19Common StockSEC:0001179110-15-013567:0
- 3,889 shares@ US$9.55Common StockSEC:0001179110-15-013567:1
- 3,889 shares@ US$3.19Common StockSEC:0001179110-15-012792:0
- 3,889 shares@ US$13.16Common StockSEC:0001179110-15-012792:1
- 3,889 shares@ US$3.19Common StockSEC:0001179110-15-011646:0
- 3,889 shares@ US$17.10Common StockSEC:0001179110-15-011646:1
- 3,888 shares@ US$3.19Common StockSEC:0001179110-15-010666:0
- 3,888 shares@ US$14.34Common StockSEC:0001179110-15-010666:1
- 15,000 shares@ US$5.35Common StockSEC:0001179110-15-008894:0
- 15,000 shares@ US$11.78Common StockSEC:0001179110-15-008894:1
- 10,000 shares@ US$5.35Common StockSEC:0001179110-15-006955:0
- 10,000 shares@ US$8.32Common StockSEC:0001179110-15-006955:1
- 10,000 shares@ US$5.35Common StockSEC:0001179110-15-005713:0
- 10,000 shares@ US$8.74Common StockSEC:0001179110-15-005713:1
25 of 107 declarations
